Literature DB >> 16731590

Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy.

Anthony G Douglas-Jones1, Jemimah L Denson, Adam C Cox, Iwan B Harries, Guy Stevens.   

Abstract

AIM: To identify and review cases of false negative needle core biopsy (NCB) in the preoperative investigation of radial scar/complex sclerosing lesion (RS/CSL) lesions - that is, benign NCB from RS/CSL which contained malignancy on excision. METHODS AND
RESULTS: A total of 11 false negative NCB in RS/CSL lesions from 281 (3.9%) were identified (6 cases: B1, 2 cases: B2 and 3 cases: B3). In 6 of 11 cases a radial scar or stromal sclerosis was seen in NCB. Localisation biopsy showed duct carcinoma in situ in six cases, duct carcinoma in situ with invasive carcinoma in three and invasive carcinoma in two. In all 11 cases, needle tracks were identified as missing the malignant epithelium by a mean of 5 mm (median:4 mm; range:1-20 mm). In 9 of 11 cases, the malignancy was missed by <6 mm.
CONCLUSIONS: Despite evidence of accurate targeting of lesions, the use of NCB instead of fine needle aspiration cytology has not eliminated the problem of false negative biopsy in RS/CSL, and excision is recommended.

Entities:  

Mesh:

Year:  2006        PMID: 16731590      PMCID: PMC1860566          DOI: 10.1136/jcp.2006.037069

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Role of sonography in evaluation of radial scars of the breast.

Authors:  M A Cohen; S J Sferlazza
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

2.  A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions.

Authors:  P J Westenend; A R Sever; H J Beekman-De Volder; S J Liem
Journal:  Cancer       Date:  2001-04-25       Impact factor: 6.860

3.  False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer.

Authors:  Varsha I Shah; Usha Raju; Dhananjay Chitale; Vikram Deshpande; Nancy Gregory; Vernon Strand
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

4.  Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.

Authors:  Tarik M Elsheikh; Jan F Silverman
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

5.  Multiple 14G stereotactic core biopsies in the diagnosis of mammographically detected stellate lesions of the breast.

Authors:  S E Kirwan; E R Denton; R M Nash; S Humphreys; M J Michell
Journal:  Clin Radiol       Date:  2000-10       Impact factor: 2.350

6.  Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?

Authors:  R James Brenner; Roger J Jackman; Steve H Parker; W Phil Evans; Liane Philpotts; Beth M Deutch; Mary C Lechner; Daniel Lehrer; Paul Sylvan; Rebecca Hunt; Steven J Adler; Nancy Forcier
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

7.  Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?

Authors:  J Shannon; A G Douglas-Jones; N S Dallimore
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

8.  Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer.

Authors:  Gelareh Farshid; Gill Rush
Journal:  Am J Surg Pathol       Date:  2004-12       Impact factor: 6.394

9.  Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?

Authors:  Jennifer N Cawson; Frank Malara; Anne Kavanagh; Prue Hill; Gnani Balasubramanium; Michael Henderson
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

10.  Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions.

Authors:  K Leifland; U Lagerstedt; G Svane
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

View more
  7 in total

1.  The radial scar of the breast diagnosed at core needle biopsy.

Authors:  Cory Morgan; Zeeshan A Shah; Raynal Hamilton; Jean Wang; Joseph Spigel; William Deleon; Patricia Deleon; Tyler Leete; J Mark Fulmer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

2.  A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme.

Authors:  G Osborn; F Wilton; G Stevens; E Vaughan-Williams; K Gower-Thomas
Journal:  Ann R Coll Surg Engl       Date:  2010-11-12       Impact factor: 1.891

Review 3.  [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].

Authors:  H-P Sinn; C Flechtenmacher; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

4.  Malignancy Upgrade Rates of Radial Sclerosing Lesions at Breast Cancer Screening.

Authors:  Pamela Yan; Linda DeMello; Grayson L Baird; Ana P Lourenco
Journal:  Radiol Imaging Cancer       Date:  2021-11

5.  Radial scar on image-guided breast biopsy: is surgical excision necessary?

Authors:  Wendy Yen Yun Chou; Deborah J Veis; Rebecca Aft
Journal:  Breast Cancer Res Treat       Date:  2018-03-12       Impact factor: 4.872

6.  Isolated radial scar diagnosis by core-needle biopsy: Is surgical excision necessary?

Authors:  Elizabeth Min Hui Kim; Andrea Hankins; Jamie Cassity; Dennis McDonald; Barbara White; Ron Rowberry; Sharon Dutton; Claire Snyder
Journal:  Springerplus       Date:  2016-03-31

7.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth Am O'Flynn; Christopher Comstock; Claudia Kurtz; Rahel Kubik; Helmut Madjar; Domenico Lepori; Gert Kampmann; Alexander Mundinger; Astrid Baege; Thomas Decker; Stefanie Hosch; Christoph Tausch; Jean-François Delaloye; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2016-08-13       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.